Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer

A large review has found no difference in overall survival with fixed-duration vs ongoing ICI treatment in progression-free non–small cell lung cancer.
Medscape Medical News

source https://www.medscape.com/viewarticle/992825?src=rss